BioSpace News Archive

Policy

VASCEPA® Approved in Canada to Reduce the Risk of Cardiovascular Events

VASCEPA becomes the first and only Health Canada approved medication for reducing cardiovascular risk beyond cholesterol lowering therapy in the studied high-risk patients approved for treatment

January 2, 2020
·
14 min read
BioMidwest

Exact Sciences to participate in J.P. Morgan Healthcare Conference

Exact Sciences Corp. announced that company management will participate in the following investor conference and invited investors to participate by webcast.

January 2, 2020
·
5 min read
Business

HEXO Corp. Files Restated Financial Statements

HEXO Corp. (“HEXO” or the “Company”) (TSX: HEXO; NYSE: HEXO) today announced it has completed the filing of its restated audited annual consolidated financial statements for the fiscal year ended July 31, 2019

January 2, 2020
·
4 min read
Business

Johnson & Johnson Announces Quarterly Dividend for First Quarter 2020

Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a cash dividend for the first quarter of 2020 of $0.95 per share on the company’s common stock.

January 2, 2020
·
1 min read
Bio NC

Aerie Pharmaceuticals Announces Acceptance for Review of the Roclanda® (netarsudil and latanoprost ophthalmic solution) 0.02%/0.005% Marketing Authorisation Application in Europe

An opinion from the EMA’s Committee for Medicinal Products for Human Use on the MAA for Roclanda® is expected in late 2020.

January 2, 2020
·
6 min read
Business

Axogen, Inc. to Participate at JP Morgan 38th Annual Healthcare Conference

The presentation is scheduled for Thursday, January 16, 2020 at 10:30 a.m. PST

January 2, 2020
·
2 min read
Pharm Country

Merck to Present at the 38th Annual J.P. Morgan Healthcare Conference

Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that Kenneth C. Frazier, chairman and chief executive officer, and Dr. Roger M. Perlmutter, president, Merck Research Laboratories, are scheduled to participate at the 38th Annual J.P. Morgan Healthcare Conference

January 2, 2020
·
3 min read
Genetown

Apellis Pharmaceuticals to Present at the 38th Annual J.P. Morgan Healthcare Conference

Conference on Tuesday, January 14, 2020 at 3:30 p.m. PT in San Francisco, CA.

January 2, 2020
·
1 min read
MediWound Continues NexoBrid’s Global Expansion Through a New Distribution Agreement in Australia, New Zealand and Singapore with Balance Medical

MediWound Ltd. announced the signing of a distribution agreement granting Balance Medical Pty Ltd. the exclusive rights to market and distribute NexoBrid® in Australia, New Zealand and Singapore for the treatment of severe burns.

January 2, 2020
·
7 min read
Business

FSD Pharma Strengthens Management Team

Donal Carroll Appointed Chief Financial Officer, Dr. Sandra Lottes as Vice President and Head of Clinical Research at BioSciences Division, and Shahzad Shah as Chief Operating Officer at FV Pharma

January 2, 2020
·
7 min read